CD47 Targeting Global Therapeutics Market 2021-2035, by Target Disease Indication, Type of Molecule Key Players and Key Geographical Regions
15 déc. 2021 04h03 HE
|
Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "CD47 Targeting Therapeutics Market Industry Trends and Global Forecasts, 2021-2035" report has been added to ResearchAndMarkets.com's offering. ...
Immunotherapy Drugs Market Outlook - Global Market Set to Reach $248.27 billion in 2025
13 déc. 2021 11h38 HE
|
Research and Markets
Dublin, Dec. 13, 2021 (GLOBE NEWSWIRE) -- The "Drugs for Immunotherapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...
Global Lumakras Drug Clinical Insight & Sales Forecast Report 2021-2026: Dosage, Patent & Price Analysis, Lumakras Ongoing Clinical Trials, Global KRAS Protein Inhibitors Clinical Trials
24 nov. 2021 03h43 HE
|
Research and Markets
Dublin, Nov. 24, 2021 (GLOBE NEWSWIRE) -- The "Lumakras Drug Clinical Insight & Sales Forecast 2026" report has been added to ResearchAndMarkets.com's offering. The report global Lumakras...
Global MEK Inhibitors Market, Drug Sales & Clinical Trials to 2026: USD 3 Billion Market Opportunity
19 nov. 2021 05h03 HE
|
Research and Markets
Dublin, Nov. 19, 2021 (GLOBE NEWSWIRE) -- The "Global MEK Inhibitors Market, Drug Sales & Clinical Trials insight 2026" report has been added to ResearchAndMarkets.com's offering. The advances...
PCI Biotech to present at the 9th International mRNA Health Conference
09 nov. 2021 03h30 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 9 November 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced...
PCI Biotech: Presentation of fimaChem for bile duct cancer at IPA masterclass series
08 nov. 2021 05h15 HE
|
PCI Biotech Holding ASA
Oslo (Norway), 8 November 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the coordinating principal investigator for the RELEASE trial, Prof. Dr. Jörg...
Global $15.1 Bn Immuno-oncology Clinical Trials Market to 2028
30 juil. 2021 07h23 HE
|
Research and Markets
Dublin, July 30, 2021 (GLOBE NEWSWIRE) -- The "Immuno-oncology Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, Phase IV), by Design...
Global Oncology Partnering Report 2021: Deal Trends, Players and Financials for 4700 Deals
21 juil. 2021 04h48 HE
|
Research and Markets
Dublin, July 21, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Partnering 2015-2021: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. The Global...
Global Autoimmune Partnering Deal Trends, Players and Financials Analysis 2014-2020: Company A-Z, Stage of Development at Signing, Deal Type and Technology Type
26 mars 2021 05h48 HE
|
Research and Markets
Dublin, March 26, 2021 (GLOBE NEWSWIRE) -- The "Global Autoimmune Partnering 2014-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering. Global...
Global Immunocytokines Market Report 2021-2030: Current and Future Potential of Immunocytokines Being Developed for the Treatment of Rheumatoid Arthritis and Various Types of Cancer
25 mars 2021 06h58 HE
|
Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "Immunocytokines Market by Indication, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2021-2030" report...